Does dermatomyositis affect the liver?

Abstract. Background. Long-term use of hormones and immunosuppressive agents is necessary for treat- ing polymyositis (PM)/dermatomyositis (DM) but may cause liver damage.

Can polymyositis affect the liver?

CD8-positive T cell-induced liver damage was found in a patient with polymyositis.

How can you tell the difference between dermatomyositis and polymyositis?

Two specific kinds are polymyositis and dermatomyositis. Polymyositis causes muscle weakness, usually in the muscles closest to the trunk of your body. Dermatomyositis causes muscle weakness, plus a skin rash. Doctors may use a physical exam, lab tests, imaging tests and a muscle biopsy to diagnose myositis.

How do you diagnose dermatomyositis?

A skin sample can help confirm the diagnosis of dermatomyositis. A muscle biopsy might reveal inflammation in your muscles or other problems, such as damage or infection. If the skin biopsy confirms the diagnosis, a muscle biopsy might not be necessary.

How long can you live with autoimmune hepatitis?

Without treatment, approximately 40% to 50% of the individuals with severe disease will die within 6 months to 5 years. Treatment with steroids has dramatically changed the course of the disease. Most patients respond to therapy and the 10-year survival rate is approximately 83.8% to 94%.

What tests confirm autoimmune hepatitis?

Your doctor will use blood tests to look for evidence of autoimmune hepatitis. Blood tests include tests that check levels of the liver enzymes alanine transaminase (ALT) and aspartate transaminase (AST) and check for autoantibodies such as antinuclear antibody (ANA) and anti-smooth muscle antibody (SMA).

What are the clinical features of dermatomyositis?

Dermatomyositis (DM) is an idiopathic inflammatory myopathy that is clinically heterogeneous and that can be difficult to diagnose. Cutaneous manifestations sometimes vary and may or may not parallel myositis and systemic involvement in time course or severity.

What is the etiology of juvenile dermatomyositis?

The exact etiology is idiopathic; however, juvenile dermatomyositis is associated with HLA DQA1 0501 Some cases have no rash or an unrecognized rash in darker skinned individuals (dermatomyositis sine dermatitis)

Who is at increased risk for dermatomyositis?

Increased risk of thyroid disease, particularly hypothyroidism, especially in patients with interstitial lung disease Chronic nonspecific dermatitis or interface dermatitis resembling systemic lupus erythematosus Sparse perivascular lymphocytic infiltrate with markedly increased dermal mucin

How is myositis changing the diagnostic landscape for dermatologists?

Recent developments in our understanding of myositis-specific antibodies have the potential to change the diagnostic landscape of DM for dermatologists.